Skip to main content
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · IEX Real-Time Price · USD
13.66
+0.34 (2.55%)
At close: Apr 30, 2024, 4:00 PM
13.75
+0.09 (0.66%)
After-hours: Apr 30, 2024, 5:52 PM EDT

TG Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 30.2, with a low estimate of 13 and a high estimate of 45. The average target predicts an increase of 121.08% from the current stock price of 13.66.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $13 $30.2 $29 $45
Change -4.83% +121.08% +112.30% +229.43%

Analyst Ratings

The average analyst rating for TGTX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24Apr '24
Strong Buy 444444
Buy 333221
Hold 111111
Sell 110000
Strong Sell 000000
Total 998776

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Edward White
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Reiterates
$45
 Strong Buy Reiterates $45 +229.43% Apr 18, 2024
Eric Joseph
JP Morgan
 JP Morgan
Buy
Reiterates
$25
 Buy Reiterates $25 +83.02% Apr 18, 2024
Matthew Kaplan
Ladenburg Thalmann
 Ladenburg Thalmann
Strong Buy
Reiterates
$39
 Strong Buy Reiterates $39 +185.51% Apr 18, 2024
Edward White
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Reiterates
$45
 Strong Buy Reiterates $45 +229.43% Mar 1, 2024
Corinne Jenkins
Goldman Sachs
 Goldman Sachs
Hold
Maintains
$12 → $13
 Hold Maintains $12 → $13 -4.83% Feb 29, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
269.13M
from 233.66M
Increased by 15.18%
Revenue Next Year
420.94M
from 269.13M
Increased by 56.41%
EPS This Year
-0.11
from 0.09
EPS Next Year
0.49
from -0.11
Year 2019202020212022202320242025202620272028
Revenue
152.00K152.00K6.69M2.79M233.66M269.13M420.94M603.63M1.03B1.39B
Revenue Growth
--4,300.66%-58.36%8,290.02%15.18%56.41%43.40%70.30%34.82%
EPS
-1.96-2.42-2.63-1.460.09-0.110.491.253.094.98
EPS Growth
-------157.72%147.15%61.22%
No. Analysts -----109744
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 341.5M 567.3M 834.8M 1.1B 1.5B
Avg 269.1M 420.9M 603.6M 1.0B 1.4B
Low 235.0M 320.4M 400.5M 927.6M 1.3B

Revenue Growth

Revenue Growth 20242025202620272028
High
46.2%
110.8%
98.3%
86.0%
46.3%
Avg
15.2%
56.4%
43.4%
70.3%
34.8%
Low
0.6%
19.0%
-4.9%
53.7%
22.5%

EPS Forecast

EPS 20242025202620272028
High 0.19 0.98 1.97 3.55 6.30
Avg -0.11 0.49 1.25 3.09 4.98
Low -0.50 -0.10 0.44 2.63 3.69

EPS Growth

EPS Growth 20242025202620272028
High
110.0%
-
306.8%
183.8%
103.8%
Avg - -
157.7%
147.1%
61.2%
Low - -
-9.1%
110.0%
19.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.